Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Coverage for amniotic and placental-derived product injections/applications is allowed only when the reasonable and necessary clinical criteria of LCD L39879 are met. Claims using HCPCS A4100 or Q4100 require detailed claim narrative (product name, amount injected, amount wasted) and must not be used for injectable skin substitutes; documentation must be complete, legible, signed, and support the ICD-10 and CPT/HCPCS codes billed.

"Amniotic and placental-derived product injections/applications are covered only when they meet the reasonable and necessary clinical requirements specified in LCD L39879 (Amniotic and Placental-Der..."

Sign up to see full coverage criteria, indications, and limitations.